Einwallner Elisa, Kiefer Florian W, Di Caro Giuseppe, Orthofer Michael, Witzeneder Nadine, Hörmann Gregor, Itariu Bianca, Zeyda Maximilian, Penninger Josef M, Stulnig Thomas M, Esterbauer Harald, Todoric Jelena
Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.
Christian Doppler Laboratory for Cardio-Metabolic Immunotherapy and Clinical Division of Endocrinology and Metabolism, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
Eur J Clin Invest. 2016 Nov;46(11):911-919. doi: 10.1111/eci.12675. Epub 2016 Oct 1.
Infiltration of white adipose tissue (WAT) by inflammatory cells in obesity is considered to be a key event in the development of insulin resistance. Recently, mast cells (MCs) have been identified as new players in the pathogenesis of obesity. We aimed to investigate the relationship between MCs and various inflammatory markers in serum and WAT and to determine the role of MCs in the aetiology of insulin resistance.
Gene expression was measured in WAT from 20 morbidly obese patients and 20 nonobese control subjects. Homoeostasis Model of Assessment-Insulin Resistance (HOMA-IR) was used to estimate insulin sensitivity. In addition, wild-type and mast cell-deficient mice were fed a high-fat or low-fat diet to study mast cell influence on inflammatory cell polarization in WAT and overall metabolic changes.
WAT levels of MC-specific TPSb2 transcript were increased in obesity and significantly positively correlated with TNF, CCL2, CCL5 and CD68 gene expression levels in our study subjects after adjustment for sex, age and BMI. Accordingly, MC deficiency abrogated increase in expression of pro-inflammatory M1 macrophage marker genes in mouse WAT upon high-fat diet feeding. However, MCs accumulated in obese human WAT independent of insulin resistance and systemic changes in inflammatory mediators.
Our results suggest that MCs contribute to the local pro-inflammatory state within WAT in obesity but do not play a primary role in causing insulin resistance.
肥胖症中炎症细胞浸润白色脂肪组织(WAT)被认为是胰岛素抵抗发展的关键事件。最近,肥大细胞(MCs)已被确定为肥胖症发病机制中的新参与者。我们旨在研究MCs与血清和WAT中各种炎症标志物之间的关系,并确定MCs在胰岛素抵抗病因中的作用。
测量了20例病态肥胖患者和20例非肥胖对照者WAT中的基因表达。采用稳态模型评估胰岛素抵抗(HOMA-IR)来估计胰岛素敏感性。此外,给野生型和肥大细胞缺陷型小鼠喂食高脂或低脂饮食,以研究肥大细胞对WAT中炎症细胞极化和整体代谢变化的影响。
在我们的研究对象中,调整性别、年龄和BMI后,肥胖症患者WAT中MC特异性TPSb2转录本水平升高,且与TNF、CCL2、CCL5和CD68基因表达水平显著正相关。因此,高脂饮食喂养后,MC缺陷消除了小鼠WAT中促炎M1巨噬细胞标志物基因表达的增加。然而,MCs在肥胖人类WAT中积聚,与胰岛素抵抗和炎症介质的全身变化无关。
我们的结果表明,MCs有助于肥胖症中WAT内的局部促炎状态,但在导致胰岛素抵抗方面不发挥主要作用。